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Abstract 
Background: Molecular detection of low-density Plasmodium falciparum infections is essential for surveillance stud-
ies conducted to inform malaria control strategies in close-to-elimination settings. Molecular monitoring of residual 
malaria infections usually requires a large study size, therefore sampling and diagnostic processes need to be eco-
nomical and optimized for high-throughput. A method comparison was undertaken to identify the most efficient 
diagnostic procedure for processing large collections of community samples with optimal test sensitivity, simplicity, 
and minimal costs.
Methods: In a reactive case detection study conducted on Zanzibar, parasitaemia of 4590 individuals of all ages was 
investigated by a highly sensitive quantitative (q) PCR that targets multiple var gene copies per parasite genome. To 
reduce cost, a first round of positivity screening was performed on pools of dried blood spots from five individuals. 
Ten cycles of a pre-PCR were performed directly on the filter paper punches, followed by qPCR. In a second round, 
samples of positive pools were individually analysed by pre-PCR and qPCR.
Results: Prevalence in household members and neighbors of index cases was 1.7% (78/4590) with a geometric 
mean parasite density of 58 parasites/µl blood. Using qPCR as gold standard, diagnostic sensitivity of rapid diagnostic 
tests (RDTs) was 37% (29/78). Infections positive by qPCR but negative by RDT had mean densities of 15 parasites/µl 
blood.
Conclusion: The approach of pre-screening reactive case detection samples in pools of five was ideal for a low 
prevalence setting such as in Zanzibar. Performing direct PCR on filter paper punches saves substantial time and justi-
fies the higher cost for a polymerase suitable for amplifying DNA directly from whole blood. Molecular monitoring in 
community samples provided a more accurate picture of infection prevalence, as it identified a potential reservoir of 
infection that was largely missed by RDT. The developed qPCR-based methodology for screening large sample sets 
represents primarily a research tool that should inform the design of malaria elimination strategies. It may also prove 
beneficial for diagnostic tasks in surveillance-response activities.
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Background
Surveillance is a key component of malaria control and 
elimination programmes [1]. Surveillance and response 
approaches require specific adaptation to the epide-
miological and operational setting in which they are 
implemented. Depending on the exact objective of the 
surveillance activities, suitable data collection strate-
gies and diagnostic tools may vary. A key interest is to 
understand population prevalence as a proxy for the 
transmission reservoir and transmission potential in a 
certain area. A number of publications have presented 
mathematical models and gametocyte data from endemic 
communities [2–6], all concurring in that, in addition to 
symptomatic malaria cases, also individuals with asymp-
tomatic as well as submicroscopic infections contribute 
to the infectious reservoir. This silent reservoir is cur-
rently under investigation in many malaria endemic 
countries, and malaria elimination programmes aim to 
uncover and potentially track this source of transmission. 
To understand the relative importance of submicroscopic 
infections, their prevalence and densities are investigated 
in community samples of low parasite density. This is 
feasible by using molecular diagnostic methods. These 
methods are employed with the expectation that such 
data from the community may help to investigate resid-
ual transmission in close-to-elimination settings.
At low endemicity, malaria is known to cluster geo-
graphically and the exposure of individuals to malaria 
infection may vary substantially within a village and over 
time [7–9]. To capture such heterogeneity in case dis-
tribution, asymptomatic malaria cases are identified in 
a reactive case detection (RCD) approach [10, 11]. RCD 
is triggered by patients reporting to a health facility and 
diagnosed with malaria, based on laboratory confirma-
tion. These index cases prompt a visit to the household 
of the patient (and sometimes to neighboring house-
holds) to identify additional malaria infections, most of 
which are expected to be asymptomatic [12]. The RCD 
strategy generally entails a targeted response, such as 
treating individuals of identified transmission foci. Thus, 
implementation of RCD aids in the containment of local 
epidemics of malaria and may help to control onward 
transmission from imported infections. Modeling indi-
cated that RCD seems to be a promising approach to 
control residual malaria by complementing non-targeted 
interventions with targeting additional interventions or 
to support elimination in areas where the transmission 
potential is very low [13].
In pre-elimination settings, such as the site of this study 
in Zanzibar, passive case surveillance and elimination 
strategies further struggle with the fact that symptomatic 
cases are rare. On the other hand, active and reactive case 
detection include asymptomatic individuals, but parasite 
densities tend to be very low and difficult to detect with 
routinely applied diagnostic tools such as RDTs or light 
microscopy (LM). Meta-analyses comparing prevalence 
rates determined by PCR versus LM have demonstrated 
that the proportion of submicroscopic P. falciparum 
infections in community samples substantially increases 
with declining malaria transmission intensity [14, 15]. 
This trend was confirmed in the past few years by numer-
ous molecular-epidemiological studies [15–21].
An extensive subpatent reservoir of malaria infec-
tions has major consequences for malaria surveillance 
activities, in particular in pre-elimination settings, 
where the aim is to interrupt local transmission. Recent 
data from a pre-elimination setting in Zambia showed 
that almost half of all infections remained undetected 
by RDT [22]. About a quarter of these infections were 
subpatent by RDT but carried gametocytes. To meas-
ure the magnitude of the infection reservoir missed 
in household surveys by employing RDTs, the current 
diagnostic tool for RCD, we undertook a molecular-
epidemiological study in a close-to-elimination setting 
on Zanzibar. This study was nested into a larger project 
(Reactive Case Detection in Zanzibar: System Effective-
ness and Cost, RADZEC) to evaluate the effectiveness 
of RCD in Zanzibar. Study details and epidemiologi-
cal results were presented elsewhere ([23]; Stuck et al. 
pers. commun.). The focus of this report is the develop-
ment and evaluation of an efficient diagnostic strategy 
for large numbers of samples collected during RCD in 
a pre-elimination setting. As samples collected from 
asymptomatic carriers in such settings mostly harbour 
low parasite densities, high diagnostic sensitivity and 
high throughput was the priority. In a low transmis-
sion setting with only few infected individuals in the 
community, molecular-epidemiological studies require 
screening of a large number of samples with high diag-
nostic sensitivity to identify the remaining infected 
individuals. A reduction of work load may be achieved 
by a sample pooling strategy prior to molecular diag-
nostics [24, 25]. Applying a multi-target molecular test 
is a precondition for both, pooling of several samples 
without losing sensitivity, and detection of asymp-
tomatic, low-density infections. A quantitative PCR 
(qPCR) that targets the P.falciparum var gene family 
(varATS us-qPCR) was previously developed to permit 
pooling without losing sensitivity [26]. The aims of this 
study, therefore, were to identify a time-efficient strat-
egy for pooling multiple DBS samples, to simplify DNA 
extraction, and to develop a diagnostic method with 
high sensitivity and robust quantitation in detecting 
submicroscopic parasitaemia.
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Methods
Study design
Since 2008, the Zanzibar Malaria Elimination Pro-
gramme (ZAMEP) has been implementing a RCD system 
[23, 27]. The RADZEC project represents a rolling cross-
sectional survey, whereby field data collectors accom-
panied district malaria surveillance officers (DMSOs) 
during follow-up visits to the households of malaria index 
cases who were detected at health facilities and flagged 
up through an electronic malaria case notification sys-
tem (index cases). After the DMSOs finished with their 
investigation of the index household and departed, study 
staff continued surveying the four nearest neighbors and 
5 households along a 200-m transect drawn in a random 
direction away from the index case household. Details 
on the study design were described previously elsewhere 
([23]; Stuck et al. personal communication). The samples 
used in this molecular analysis were collected between 
June 1, 2017 and August 13, 2018.
The molecular epidemiological study consisted of a 
subsample of 156 clusters from the full rolling cross sec-
tional study, each representing a follow-up investigation 
of an index case on Pemba and Unguja islands of the 
Zanzibar archipelago, Tanzania. From a large sample 
collection, clusters were selected for molecular analyses 
which contained samples from at least seven households. 
Each cluster included members of the index case house-
hold, of the four nearest neighbouring households and 
five transect households. A total of 664 residents of index 
case households were included, as well as 1955 members 
of neighbouring and 1971 of transect households. The 
index cases themselves were not included as they already 
had received treatment at the health facility 1 to 2 days 
prior to the follow-up household visit.
Sample collection, storage and transport
During the follow-up household visits, usually within 
5 days after the reporting of an index case, capillary blood 
was collected by finger prick from all consenting house-
hold members and neighbors older than 3  months. A 
malaria RDT (SD BIOLINE Malaria Ag Pf/Pan (Abbott)) 
was performed for on-the-spot malaria diagnosis. The 
DMSO treated all RDT-positive individuals within the 
index household according to the national guidelines. 
Individuals testing positive in non-index households, in 
which the DMSO was not present, were referred to the 
nearest health facility. A 100–150  µl whole blood sam-
ple was directly added to a pre-folded Whatman 3MM 
filter paper. Blood spots were dried in the field and then 
packed in individual plastic bags with desiccant and 
humidity indicator papers. Dried blood spots (DBS) were 
unpacked and re-dried after transport to the study office, 
re-packed with desiccant and humidity indicator paper, 
sealed in a zip-lock plastic bag and thereafter stored at 
room temperature.
Preparation of dried blood spots with known parasite 
densities
For assay development and optimization, P. falcipa-
rum strain 3D7 was cultured in  vitro and parasitaemia 
was determined by microscopy. To mimic an infected 
blood sample, 3D7 culture was diluted in malaria-nega-
tive whole blood to parasite densities ranging from 0.05 
parasites/µl to  104 parasites/µl. Negative controls con-
sisted of whole blood from an uninfected volunteer. To 
simulate the conditions of DBS collected in the RADZEC 
study, blood of this volunteer was spotted in 50  µl ali-
quots onto Whatman 3MM filter paper, air dried over-
night and stored at room temperature in plastic bags with 
desiccants.
Comparison of DNA extraction by chelex, glassmilk, 
boil‑and‑spin to direct pre‑PCR
For DNA extraction, five 3  mm discs were punched 
from the DBS using a hand-held paper craft punch. var-
ATS qPCR (details described below) was used to com-
pare four different DNA extraction methods for DBS: 
(i) Chelex extraction was performed according to Plowe 
and co-workers, with minor modifications, such as two 
washing cycles with PBS instead of one, and omitting 
an incubation step in PBS for 15  min during PBS wash 
[28]. (ii) For boil-and-spin extraction, punches were 
incubated over night at 4  °C in 0.5% saponin/phosphate 
buffered saline (PBS). Saponin was removed after incu-
bation and punches were washed twice by adding 1  ml 
of PBS, inverting tubes several times, spinning down 
briefly and removing PBS. Punches were transferred into 
a clean 1.5 ml Eppendorf tube and centrifuged briefly to 
collect and remove any remaining liquid. 50  µl ddH2O 
was added and samples were boiled at 95 °C for 30 min. 
Tubes were centrifuged for 5 min at 14,000 rpm. 25 µl of 
DNA solution was transferred into a new tube. (iii) Boil-
and- spin plus glassmilk purification: After boil-and-spin 
extraction, DNA was purified using glassmilk (MP Bio-
medicals) according to the supplier’s instructions. (iv) 
Direct amplification of P. falciparum DNA in pre-PCR 
(details of final protocol described below) did not require 
any processing of punches from DBS. Four alternative 
polymerases for direct pre-PCR were tested during assay 
optimization: Phusion Blood Polymerase (Thermo Fisher 
Scientific), 2X KAPA HiFi HotStart (KAPA Biosystem), 
Hemo KlenTaq Polymerase (NEB), MyTaq DNA Poly-
merase (Bioline). Protocols and test results are provided 
in Additional file  1: Tables S1–S10. Experiments were 
performed at Swiss TPH, Basel, Switzerland.
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Molecular diagnosis in community samples
The bulk of samples to be analysed originated from 
RDT-negative household members. For detection of 
P. falciparum infections, samples collected from RDT-
negative individuals were screened by pre-PCR/qPCR 
using a two-step process. First, pools of five samples 
were screened using one 3 mm punch per sample (one 
punch is equivalent to 3–4 µl of whole blood). In a sec-
ond step, samples from positive pools were screened 
individually using five 3 mm punches per sample (equal 
to 15  µl of whole blood). Samples from RDT-positive 
household members and from index cases were pro-
cessed separate from RDT-negative individuals and 
were directly screened individually in pre-PCR/qPCR 
using five 3 mm punches.
Direct‑on‑DBS pre‑PCR
P.falciparum DNA was amplified directly from DBS 
punches using Phusion Blood Direct PCR Kit (Thermo 
Fisher Scientific). Primers targeted the conserved 
C-terminal region of the multi-copy var gene fam-
ily [26]. A 55 µl reaction contained 1× Phusion Blood 
Buffer supplemented with 150  µM nucleotides and 
450 nM forward and reverse primers (final concentra-
tion), 1  µl Phusion Blood Polymerase and five 3-mm 
punches. Cycling conditions were 98 °C for 5 min, fol-
lowed by 10 cycles of 98 °C for 15 s, 55 °C for 30 s and 
72 °C for 30 s. Pre-amplified PCR products were diluted 
1:50 and used as template in varATS qPCR.
Quantitative PCR
varATS qPCR was performed using 4 µl of diluted pre-
amplification product or DNA extracted by various 
approaches during comparison of extraction methods. 
The 12 µl reaction contained 1× GoTaq Probe Master-
mix (Promega), 833  nM forward and reverse primer, 
and 416 nM probe (final concentrations). Cycling con-
ditions in an ABI StepOne System were 95 °C for 2 min, 
45 cycles of 95 °C for 15 s and 55 °C for 1 min. Parasite 
density was determined using a tenfold dilution row 
of the WHO  1st international standard for P. falcipa-
rum DNA Nucleic Amplification Techniques (NIBSC), 
ranging from 4880 to 0.048 parasites/µl (the two lowest 
concentrations were run in duplicate). For direct-on-
DBS pre-PCR followed by qPCR, this DNA standard 
was included in qPCR analysis starting from the pre-
amplification step. In order to ensure equal amplifica-
tion conditions of standard DNA and DBS samples, 
one 3-mm punch from a malaria-negative DBS was 
added to the pre-amplification reactions containing the 
standard DNA dilution. Two types of negative controls 
were used for all analyses: (i) parasite-negative DBS 
processed alongside samples through all extraction and 
amplification procedures, and (ii), 4 µl  ddH2O added as 
blank to qPCR mix.
Reproducibility, limit of detection (LOD), introduction 
of cut‑off of parasite quantification by pre‑PCR/qPCR
Reproducibility
Intra- and inter-assay variance, assessed by calculating 
the coefficient of variation (CV) for Ct values (expressed 
in %) were determined by testing replicate DNA dilution 
rows of the WHO 1st international standard for P. falci-
parum DNA Nucleic Amplification Techniques (NIBSC), 
supplemented with negative DBS punches as described 
above. Intra-assay variation was determined using 5 rep-
licates of eight serially diluted samples (corresponding to 
48,800, 4880, 488, 48.8, 4.88, 2.44, 0.488, and 0.244 para-
sites/µl), supplemented with 5 negative DBS punches, 
within a single pre-PCR/qPCR run. Inter-assay variation 
was determined using six serially diluted samples (corre-
sponding to 4880, 488, 48.8, 4.88, 0.488, and 0.048 para-
sites/µl), supplemented with one negative DBS punch, in 
28 separate pre-PCR/qPCR runs.
Limit of detection (LOD)
The LOD was determined separately for the two PCR 
rounds: (i) screening of sample pools (one 3  mm DBS 
punch per sample in the pool) and (ii) testing of indi-
vidual samples (using five 3 mm DBS punches). For this 
purpose, serial dilutions of the WHO DNA standard 
(NIBSC) were made and combined with punches from 
DBS impregnated with uninfected human whole blood. 
Pre-PCR and qPCR were performed in quintuple on 12 
dilutions (corresponding to 48,800, 4880, 488, 48.8, 4.88, 
2.44, 0.488, 0.244, 0.122, 0.048, 0.024, and 0.0048 para-
sites/µl). The LOD was determined using 3 µl and 15 µl of 
DNA, supplemented with 1 and 5 negative DBS, respec-
tively, which represents the LODs using 1 and 5 punches 
from field sample DBS. A probit model was used to pro-
duce a regression line based on experimental replicates of 
the dilution series. The LOD was 1.12 parasites/µl for 3 µl 
of DNA (95 CI [0.39–27.81]) and 0.13 parasites/µl (CI95 
[0.07–2.32]) for 15 µl DNA (Fig. 1). Hence, using five-fold 
more template material increased sensitivity 8.6-fold.
Cut‑off setting
Since qPCR positivity for a sample of low parasitaemia 
strongly depends on a stochastic distribution of scarce 
parasites on the DBS, a positivity cut-off based on the 
LOD was introduced. The selected LOD of 0.13 para-
sites/µl permits detection of a parasite infection with 
95% sensitivity when pools of 5 punches per DBS are ana-
lysed. This cut-off value for positivity was applied for all 
diagnostic assays performed on community samples.
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Results
Comparison of extraction/amplification methods for DBS
In search of the best suitable protocol for processing 
pooled DBS from large community surveys, the most 
sensitive and time-efficient combination of extraction 
and amplification was identified. To this end, test sam-
ples, ranging from  104 parasites/µl to 0.05 parasites/µl, 
were analysed by chelex extraction, boil-and-spin extrac-
tion, boil-and-spin extraction followed by glassmilk 
purification, and pre-PCR performed directly on DBS 
punches (direct pre-PCR) (Fig.  2) followed by varATS 
qPCR. Direct pre-PCR was the most sensitive method, 
giving positive results in 3/4 replicates of very low para-
site densities (0.1 parasites/µl–0.05 parasites/µl) with 
least variation in measured densities between replicates. 
The direct pre-PCR also represents the least labori-
ous method, as it requires no processing of DBS before 
PCR analysis. The second- and third- best methods were 
chelex extraction and boil-and-spin extraction, respec-
tively. The least sensitive method was boil-and-spin fol-
lowed by glassmilk purification. Because direct pre-PCR 
proved the fastest and most sensitive of all tested meth-
ods, this approach was chosen as standard procedure for 
the RADZEC RCD samples.
Validation of parasite quantification
Prior to analysing DBS from study participants, parasite 
quantification was validated when performing direct-on-
DBS pre-PCR. A tenfold dilution row of 3D7 parasites 
in whole blood spotted onto filter paper was analysed in 
parallel to a tenfold dilution row of the WHO 1st inter-
national standard for P. falciparum DNA Nucleic Ampli-
fication Techniques (NIBSC). To ensure that dilutions of 
Fig. 1 Limit of detection of varATS qPCR determined by probit 
analysis. Based on a serial dilution of WHO standard material using 
either 3 µl of DNA supplemented by one negative DBS punch 
(representing LOD using 1 punch per DBS sample, light blue) or 15 µl 
of DNA supplemented with five negative DBS punches (representing 
LOD using 5 punches per DBS sample, dark blue)
Fig. 2 Comparison of Ct-values obtained by 4 DNA extraction methods in a P. falciparum dilution row spotted on DBS. Direct pre-PCR (blue), chelex 
extraction (red), boil and spin extraction followed by glassmilk purification (green) and boil and spin extraction (purple). Experimental replicates are 
represented by the same symbol
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WHO DNA standard and of 3D7 parasites were ampli-
fied under the same conditions, DBS by supplementing 
the WHO standard dilutions with DBS impregnated with 
uninfected blood for the pre-PCR step were mimicked. 
This was necessary, as pilot experiments had shown that 
the Phusion mastermix amplified purified DNA more 
efficiently when a negative DBS was added to the mas-
termix than purified DNA alone (Additional file 1: Figs. 
S1 and S2). This may be due to an optimization of Phu-
sion direct blood kit specifically for DNA amplification in 
the presence of blood. Our experiments showed a qPCR 
efficiency of only 83% when the WHO standard DNA 
alone was pre-amplified in Phusion mastermix. In con-
trast, efficiency was 94% for DBS punches carrying the 
3D7 culture dilution. Addition of a P. falciparum-nega-
tive DBS punch to pre-PCRs with WHO standard DNA 
restored qPCR efficiency to 100% (Additional file 1: Fig. 
S1).
To assess the reproducibility of quantification, intra- 
and inter-assay CV was determined by serial dilutions of 
the WHO standard DNA (Table  1A and B). Intra-assay 
CV of replicates ranged between 0.39 and 5.65% for dif-
ferent dilutions. These experiments used serially diluted 
DNA samples (in quintuplicate, supplemented with nega-
tive DBS) using 3 µl of DNA. When 15 µl of DNA were 
used, intra-assay CV ranged from 0.64 to 2.49%. Results 
were equally reproducible between runs, with inter-assay 
CV ranging between 0.93 and 3.49% for the different 
dilutions.
Sensitivity after applying a robust density cut‑off
Because many study participants carried very low para-
site densities, we tested the reproducibility of parasite 
detection specifically in low-density field samples by 
repeating molecular diagnosis in independent repli-
cates. Starting from the original DBS and using 5 DBS 
punches per sample, triplicates were analysed for 10 
field samples with less than 0.1 parasites/µl, thus all 
representing samples that were positive but with den-
sities below the cut-off set at 0.13 parasites/µl. Positiv-
ity for all 10 samples in at least one of the triplicates 
was confirmed. For 6/10 samples at least 2 replicates 
were positive. These results confirm that such very 
low-density infections are true positives and emphasize 
how much the detection of such infections by qPCR is 
determined by stochastic distribution of template in 
the starting material. Despite the repeated detection 
of low-positives with densities below 0.1 parasites/µl, 
a cut-off for qPCR-positivity at 0.13 parasites/µl was 
Table 1 Reproducibility of P. falciparum quantification by qPCR
A. Intra-assay variation of varATS standard curve determined via Ct-values of eight serially diluted DNA samples (in quintuplicate, supplemented with negative DBS) 
using either 3 µl of DNA (equal to one punch per DBS) or 15 µl of DNA (equal to five punches per DBS)
B. Inter-assay variation of varATS standard curve determined via Ct-values of six serially diluted DNA samples (supplemented by negative DBS) using 3 µl of DNA 
(equal to one punch per DBS) in 28 replicates
A
Parasites/µl Mean (Ct) SD %CV
3 µl 15 µl 3 µl 15 µl 3 µl 15 µl
48,800 19.19 18.05 0.15 0.45 0.81 2.49
4880 20.63 19.41 0.06 0.25 0.28 1.26
488 24.34 22.68 0.12 0.24 0.50 1.06
48.8 27.58 25.95 0.12 0.17 0.45 0.64
4.88 31.12 29.76 0.12 0.25 0.39 0.83
2.44 31.91 30.40 0.63 0.49 1.99 1.62
0.48 35.61 32.83 2.01 0.46 5.65 1.39
0.24 34.98 33.78 1.12 0.98 3.20 2.89
B
Parasites/µl Mean (Ct) SD %CV
4880 20.39 0.22 1.07
488 23.72 0.26 1.09
48.8 27.17 0.25 0.93
4.88 30.47 0.38 1.25
0.488 33.35 0.9 2.68
0.048 34.76 1.21 3.49
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introduced, i.e. the LOD at which samples are detected 
with 95% probability. This cut-off may exclude some 
very low positive samples.
The stochastic distribution of parasite in samples 
with very low densities concentrations also affected our 
sample screening strategy: samples were first screened 
in pools of 5 samples with 1 DBS punch per sample, 
while the follow-up screens were performed on indi-
vidual samples using 5 DBS punches, the latter aimed at 
reducing the stochastic effects. To understand the con-
sequences of the stochastic parasite distribution when 
pooling 5 field samples for initial screening, we assessed 
the proportion of samples missed by this pooling strat-
egy. For this purpose, 48 pools were randomly selected, 
corresponding to 240 individual samples, which all had 
been qPCR-negative in the first screening round. These 
240 originally negative samples were screened individ-
ually using five punches per DBS. Before applying the 
cut-off for positivity, 18 low-positive individual samples 
(7.5%; 18/240) we found with densities of 0.01 para-
sites/µl–2.03 parasites/µl. When applying the chosen 
cut-off of 0.13 parasites/µl, 10 low-positive individuals 
(4.2%; 10/240) with densities of 0.13–2.03 parasites/
µl remained positive and 8 individuals were below the 
cut-off of 0.13 parasites/µl and to be considered nega-
tive. Thus, in this small subset of samples, we showed 
empirically a loss in positivity by both, the cut-off for 
density and the stochastic distribution of low parasite 
densities on the DBS. Nevertheless, to maintain con-
sistency in the database, all 18 positive samples newly 
identified in this additional experiment performed with 
in 48 originally negative pools were recorded negative 
in the final database as per protocol for community 
screening and analysis.
Quality assurance for processing DBS from areas of very 
low prevalence and density
In order to validate the risk of cross-contamination on 
pre-PCR/qPCR plates, the following was repeated: (i) 22 
samples with densities below 8 parasites/µl derived from 
RDT-positive household members of symptomatic index 
cases. These were repeated (in triplicate) because all sam-
ples from RDT-positive individuals, some of which with 
potentially very high parasite densities representing a risk 
for cross-contamination, were screened on a common 
PCR plate. All 22 low-positive samples were confirmed in 
independent repeat analyses. (ii) Molecular diagnostics 
on 7 RDT-negative field samples that had densities below 
2 parasites/µl and had been identified in pools that con-
tained a high-positive sample. Positivity was confirmed 
for all these samples. No further replicates were per-
formed because of limited sample material.
Prevalence of infection in community members from 156 
clusters
Direct-on-DBS pre-PCR was performed on samples 
from 4590 individuals derived from 156 clusters, each 
triggered by an index case. 664 individuals belonged to 
the households of index cases, the remainder belonged 
to neighbouring and transect houses. By RDT, 0.7% of 
all individuals were P. falciparum-positive. Positivity by 
qPCR was 1.7% (Table 2). Of 33 RDT-positive individu-
als, 29 were confirmed positive by qPCR. RDT detected 
37% (29/78) of qPCR-positive samples.
The sensitivity of RDT compared to qPCR as gold 
standard was 37.2%, while the specificity was 99.9% 
(Table  3). Most individuals with a P. falciparum density 
below 100 parasites/µl were RDT-negative, whereas the 
majority of those with a density of 100 parasites/µl or 
higher were RDT-positive (Fig. 3).
Discussion
Sensitive detection and accurate quantification of low-
density P. falciparum infections from DBS has become 
increasingly important in the context of describing resid-
ual malaria transmission in close-to-elimination settings. 
In areas of highly heterogeneous transmission it is of 
interest to identify risk factors of residual infections and 
to understand the infectious reservoir in the population. 
To provide optimal protocols for large-scale molecular-
epidemiological studies in a pre-elimination setting, a 
simple but sensitive method combining pooling, extrac-
tion and amplification was developed. This strategy 
Table 2 Number of  study participants that  were P. 
falciparum-positive or -negative by RDT and qPCR
RDT result qPCR result
Negative 99.3% (4557/4590) 98.3% (4512/4590)
Positive 0.7% (33/4590) 1.7% (78/4590)
Table 3 Comparison of RDT with qPCR results
RDT negative RDT positive Total
qPCR negative
 Frequency 4508 4 4512
 Percentage 99.9 0.09 100
qPCR positive
 Frequency 49 29 78
 Percentage 62.8 37.2 100
Total
 Frequency 4557 33 4590
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consisted of direct pre-PCR of pooled 3-mm punches 
from DBS, followed by varATS qPCR.
Despite using a single DBS punch in a pool of 5 sam-
ples, the tested method was able to reliably identify 1 
parasite/µl blood in a dilution series where DBS were 
reconstituted with WHO parasite density standard 
mixed with uninfected blood. The ultra-sensitive qPCR 
assay applied in this study targets multiple copies of P. 
falciparum var genes. A higher number of templates 
per parasite contributes to robust results in low-den-
sity infections and pools of these [26]. Nonetheless, the 
uneven distribution of the parasites in blood spotted on 
DBS poses an additional limiting factor. Hence, the sen-
sitivity of our method might be slightly overestimated, 
as the WHO density standard was added as a DNA 
solution directly into the PCR mastermix, thus more 
even distribution of templates compared to spotting 
parasites. This discrepancy cannot be bypassed, because 
the use of an international reference standard is indis-
pensable for inter-laboratory comparisons. The level 
of sensitivity of our method complies with the malERA 
consultative group-recommended detection limit for 
malaria pre-elimination settings of 1 parasite/µl blood 
[29]. Another previously published pooling approach 
used chelex extraction followed by cytochrome b nested 
PCR and reported a 100% sensitivity to detect a single 
positive sample with a density of 100 parasites/µl blood 
in a pool of 5 samples, and a 80% sensitivity to detect an 
infection of 10 parasites/µl in pooled analysis [25]. Com-
pared to this previous study, the limit of detection was 
substantially more sensitive with 95% sensitivity to detect 
1.12 parasites/µl blood on a single positive DBS punch 
screened in pools of five punches, i.e. together with 4 
negative DBS. As both studies use multi-target qPCRs, 
this difference seems to be due to the chelex extraction 
used in this previous study. The chelex protocol has the 
advantage of being low-cost, but its disadvantage consists 
in a dilution of DNA in a larger volume than the origi-
nal volume of blood, thus, sensitivity is compromised. It 
should be emphasized that for standardization sake, we 
measured both, LOD and CV, using the WHO standard 
DNA mixed with negative blood on DBS. The difference 
between introducing DNA or parasites into a reaction 
is that DNA in solution is more evenly distributed than 
when all target copies were contained in parasites. Owing 
to multi-copy genomic targets of the varATS qPCR assay, 
the values for LOD and CV could prove slightly less sen-
sitive, if whole parasites were analysed.
The ultra-sensitive diagnostic assay used in this study 
targets the P. falciparum var genes. These species-spe-
cific middle-repetitive sequences are dispersed through-
out the genome [26]. Other Plasmodium species also 
occur in the study area [16], but these were not investi-
gated so far. qPCR assays of comparable sensitivity were 
not yet available. For P. vivax, qPCR [30] and LAMP [31] 
assays were developed that detect mitochondrial DNA, of 
which numerous concatenated copies exist per parasite 
[32]. Mining of the P. vivax genome for species-specific, 
repetitive sequences identified a non-coding subtelom-
eric repeat, Pvr47 [33], yet, the Pvr47 copy number per 
genome (n = 14) was not higher than that of mitochon-
drial DNA. To our knowledge, no middle-repetitive 
sequences of higher copy-number than mtDNA have 
been identified and validated so far for qPCR diagnosis of 
the other human Plasmodium species.
Other methods than qPCR could be employed for reac-
tive case detection. Loop-mediated isothermal ampli-
fication (LAMP) was used in Zanzibar in earlier studies 
[34]. However, LAMP was less sensitive than qPCR for 
detection of asymptomatic low-density infections [34]. 
Other disadvantages of LAMP are high prize for com-
mercial LAMP kits, false positive results often arising 
from home-made master mixes, and the lack of parasite 
quantification (own unpublished observations, [30]). In a 
previous study in febrile children from Tanzania, the per-
formance of the us-qPCR assay used here was compared 
with that of conventional RDT or highly sensitive RDT 
[35]. This earlier study showed that us-qPCR was sub-
stantially more sensitive in detecting low-density infec-
tion in children suffering from non-malarial fevers.
The advantage of direct-on-DBS pre-PCR is that the 
time-consuming extraction and purification of DNA is 
omitted, such as an overnight incubation in saponin as 
required in the chelex extraction. Punching disks from 
DBS is the most time-consuming step in the processing 
of samples. All DNA extraction methods equally require 
this initial step. Substantial time is saved by performing 
Fig. 3 Proportion of P. falciparum density in RDT negative and RDT 
positive individuals detected by qPCR. Boxplot with median and IQR. 
Dotted line indicates parasite concentration 100 parasites/µl blood
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a pre-PCR amplification instead of chelex extraction, 
which reduces the processing time for 80 samples from 
2 to 1 day. Pooling of punches from several DBS permits 
analysis of even more blood samples within 1 day. Reduc-
tion of processing time by pre-PCR justifies higher costs 
incurring from the requirement for a Phusion Blood 
Direct PCR Kit. The price per sample for the direct-on-
punch pre-PCR method is around 2.4 US$ compared 
to 0.03 US$ per sample for chelex extraction. Introduc-
tion of pre-PCR permitted to introduce the highest 
possible concentration of parasite DNA into the ampli-
fication reaction. All alternative methods tested would 
have introduced less template into the qPCR mix, as 
pre-PCR overcomes loss of DNA during the extraction 
process. The major disadvantage of performing pre-PCR 
directly on filter paper was its high potential for con-
tamination. Ten cycles of pre-amplification directly on 
DBS harbors dangers, mainly because it requires transfer 
of amplified product from pre-PCR into a second reac-
tion tube or plate for qPCR. Such an open tube system 
requires utmost care because amplicons can potentially 
be transferred via aerosols or spills to neighboring wells 
leading to false positive results. The risk of contamina-
tion increases with increasing parasite density on the 
DBS. This risk requires an upscale in safety measures 
and controls as well as an adequate laboratory set up. In 
this study, the risk for contamination was minimized by 
dedicated rooms for master mix preparation, punching 
of samples, handling of post amplification product, and 
final qPCR reaction setup. Importantly, surfaces were 
decontaminated by exposure to UV light and bleach prior 
to and after completion of pipetting. Several negative 
controls were included in pre-PCR as well as qPCR to 
monitor any contamination. Despite installing preventive 
measures to avoid contamination, occasionally a no-tem-
plate-control turned out positive. This could derive from 
aerosols or pipetting error. In case of contamination, all 
samples analysed in that experiment were repeated start-
ing from new DBS punches. One way to further mini-
mize cross-contamination, also employed in this study, 
was to analyse pools with high parasite concentrations 
(including all cases of symptomatic malaria) separately 
from low-density samples.
A relevant consideration in a molecular-epidemiolog-
ical study is that pooling of samples from several indi-
viduals trades off test-sensitivity against the potential for 
high-throughput processing. This is because pooling of 
DBS reduces sensitivity of parasite detection because of 
a smaller blood volume processed. Due to space limits in 
reaction tubes, only five punches of 3 mm diameter cor-
responding to 3 µl blood each could be processed using 
our method. When samples were analysed individu-
ally, all five punches derived from one DBS, whereas for 
analysis of sample pools, only one punch per DBS could 
be processed.
During evaluation of the difference in LOD between 
the analysis of one sample (5 punches per DBS) versus 
a pool of 5 samples (one punch each), 8.6-fold loss in 
sensitivity was observed for pooling compared to indi-
vidual screening. The thus reduced sensitivity by process-
ing pools is in the sensitivity range of current molecular 
diagnostic assays used for screening of community sam-
ples. Using the varATS us-qPCR compensated partly for 
the loss of sensitivity through pooling.
For processing a large set of samples from low-trans-
mission settings as in this study, performing an initial 
screen on sample pools was necessary. When evaluat-
ing the potential to miss samples through pooling, 7.5% 
(18/240) low-positive samples would be gained by indi-
vidual analysis, 10/240 (4.2%) would be positive above 
the cut-off. These numbers highlight the limitations in 
large studies and reporting the potential for false nega-
tives is relevant. However, in the context of investigating 
the extent of the asymptomatic parasitaemia in the com-
munity, there is no need to identify the full depth of the 
subclinical reservoir, as such very low-density infections 
are unlikely transmitted [36].
This equally applies to definition of a density cut-off. 
A cut-off for qPCR-positivity of 0.13 parasites/µl blood 
was introduced to compensate for the variance caused by 
stochastic distribution of scarce parasites. Using the cut-
off of 0.13 parasites/µl leads to omission of all low posi-
tive samples that would not be detected with certainty of 
less than 95%. Although samples below this cut-off were 
detected in some independent replicates, a very robust 
data set was created with records of positive samples that 
would be reproduced if repeatedly analysed.
Earlier Mass Screening and Treatment (MSAT) cam-
paigns relying on RDT-based or LM-based diagnosis 
have not produced convincing results: Studies in Bur-
kina Faso and Zanzibar found no sustained effect on 
incidence of anti-malarial treatment of asymptomatic 
P. falciparum carriers after screening and treatment 
campaigns [37, 38]. A population-wide malaria test-
ing and treatment with RDTs and artemether-lumefan-
trine in southern Zambia, an area with heterogeneous 
transmission, showed an overall modest impact on 
decreasing the malaria infection burden [39]. A recent 
study in Indonesia reported similar results; after two 
or three rounds of MSAT using microscopy, little or no 
impact on malaria incidence was found [40]. Such lit-
tle effect on incidence and prevalence is likely due to 
the large proportion of missed low-density infections, 
which will sustain transmission despite treatment of 
RDT-positive infections. A recent study in Zambia, 
performed in a close-to-elimination setting, showed 
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that almost half of all PCR-diagnosed infections 
remained undetected by RDT, and about a quarter of 
these RDT-negative infections carried gametocytes 
and, therefore, may be infectious to mosquitoes [22].
The results obtained in Zanzibar are in line with 
previous observations of additional detection of P. 
falciparum infections by PCR [16, 41, 42]. The abso-
lute numbers of infections detected by performing 
us-qPCR were small, with 45 infections detected addi-
tionally to RDT-positive individuals in a total of 4590 
blood samples screened. RDT detected only 29 of the 
78 qPCR-positive individuals and had a diagnostic 
sensitivity of 37%. Thus, to inform targeted response 
interventions, such as focal testing and treatment, 
RDT alone might not be sufficiently sensitive. How-
ever, it remains to be shown by further epidemiologi-
cal analyses of these data from the Zanzibar household 
surveys, whether both diagnostics reveal the same epi-
demiological patterns and risk factors for infection in 
the various household types. Performing molecular 
diagnostics in the framework of elimination research 
represents a relevant expansion into a not yet well 
characterized, potential reservoir of infection.
It has to be emphasized that detection of very low-
density infections is not trivial, and their detection 
is not necessary in many malariological studies [43]. 
However, low-density infections are relevant in stud-
ies like this one, aiming at a better understanding of 
transmission patterns. Even though low-density infec-
tions are unlikely to be transmitted at the time point of 
sampling, they might be transmitted later in the course 
of the infection. Thus, recording low-density infec-
tions with parasite densities from 1 to 10 parasite/µl 
generates more accurate and meaningful prevalence 
data compared to RDT-based data [2, 44]. Apply-
ing molecular tools in elimination research is useful 
for better understanding transmission patterns and 
underlying transmission risk in residual transmission 
scenarios and for the design and evaluation of targeted 
interventions.
In contrast to research studies, only cheap and sim-
ple-to-use methods, such as LM or RDT, are generally 
available for routine surveillance. Although the devel-
oped approach simplifies malaria diagnosis from DBS 
and supports high throughput screening, molecular 
diagnostic for programmatic use and routine imple-
mentation does not seem realistic currently, mainly 
due to a lack of funding, capacity and appropriate lab-
oratory set-up. On the other hand, molecular parasite 
detection is very useful as a research tool for gaining 
knowledge on foci of residual malaria or the silent res-
ervoir of transmission, as well as for informing math-
ematical modelling.
Conclusions
A qPCR-based pooling approach was developed and 
applied that allows high-throughput and ultra-sensitive 
detection of P. falciparum DNA from DBS. This diag-
nostic approach applies pre-PCR amplification, which 
circumvents DNA extraction and facilitates pool-
ing of five samples, but at the same time increases the 
risk of contamination. Thus, a laboratory set-up dedi-
cated to PCR work is essential. This approach is suit-
able to quantify low-density P. falciparum infections 
in research studies aiming to better understand resid-
ual transmission or to generate accurate prevalence 
data for intervention monitoring and guiding targeted 
interventions.
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